$323 Million is the total value of Sio Capital Management, LLC's 52 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 61.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LH | Buy | LABORATORY CORP AMER HLDGS | $33,939,049 | -0.9% | 168,809 | +19.0% | 10.50% | +20.6% |
| GMED | Buy | GLOBUS MED INCcl a | $25,668,107 | +102.8% | 516,981 | +143.2% | 7.94% | +146.8% |
| Buy | GSK PLCsponsored adr | $18,451,250 | +8.0% | 509,000 | +6.1% | 5.71% | +31.4% | |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $18,432,347 | +4.5% | 81,606 | +2.1% | 5.70% | +27.1% |
| CI | Sell | THE CIGNA GROUP | $16,656,712 | -47.3% | 58,226 | -48.3% | 5.16% | -35.9% |
| Sell | GE HEALTHCARE TECHNOLOGIES I | $16,486,636 | -66.2% | 242,308 | -59.6% | 5.10% | -58.8% | |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $16,010,384 | -35.2% | 796,933 | -17.7% | 4.96% | -21.2% |
| PFE | New | PFIZER INC | $14,949,719 | – | 450,700 | +100.0% | 4.63% | – |
| OGN | Buy | ORGANON & CO | $13,315,120 | +58.0% | 767,000 | +89.4% | 4.12% | +92.3% |
| TFX | New | TELEFLEX INCORPORATED | $12,666,677 | – | 64,491 | +100.0% | 3.92% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $12,550,140 | – | 15,250 | +100.0% | 3.88% | – |
| MDT | New | MEDTRONIC PLC | $8,680,721 | – | 110,780 | +100.0% | 2.69% | – |
| New | EMBECTA CORP | $8,552,825 | – | 568,294 | +100.0% | 2.65% | – | |
| HCSG | New | HEALTHCARE SVCS GROUP INC | $8,451,502 | – | 810,307 | +100.0% | 2.62% | – |
| OFIX | New | ORTHOFIX MED INC | $8,359,000 | – | 650,000 | +100.0% | 2.59% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $8,236,948 | – | 73,400 | +100.0% | 2.55% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $7,909,844 | – | 884,770 | +100.0% | 2.45% | – |
| VKTX | Buy | VIKING THERAPEUTICS INC | $6,586,672 | -23.0% | 595,002 | +12.8% | 2.04% | -6.3% |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $5,993,902 | – | 2,081,216 | +100.0% | 1.86% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $5,879,112 | – | 222,947 | +100.0% | 1.82% | – |
| CNTA | Sell | CENTESSA PHARMACEUTICALS PLCsponsored ads | $4,897,085 | -9.8% | 756,891 | -13.7% | 1.52% | +9.8% |
| SBTX | Buy | ARS PHARMACEUTICALS INC | $4,180,344 | +15.0% | 1,105,911 | +103.8% | 1.29% | +39.9% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $4,138,758 | – | 248,127 | +100.0% | 1.28% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $4,079,973 | – | 24,129 | +100.0% | 1.26% | – |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $3,928,211 | +9.7% | 342,477 | +142.0% | 1.22% | +33.5% |
| IMGN | Sell | IMMUNOGEN INC | $3,693,758 | -20.4% | 232,751 | -5.4% | 1.14% | -3.1% |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $3,556,786 | -0.5% | 288,466 | -0.8% | 1.10% | +21.1% |
| SVRA | Sell | SAVARA INC | $3,387,825 | +4.9% | 896,250 | -11.3% | 1.05% | +27.8% |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $3,376,995 | +20.9% | 635,969 | +117.0% | 1.04% | +47.2% |
| ADCT | Sell | ADC THERAPEUTICS SA | $2,955,197 | -65.8% | 3,294,534 | -18.1% | 0.92% | -58.4% |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $2,832,913 | -16.5% | 2,599,003 | +48.6% | 0.88% | +1.6% |
| RVMD | New | REVOLUTION MEDICINES INC | $2,012,336 | – | 72,700 | +100.0% | 0.62% | – |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $1,996,709 | +13.9% | 74,007 | -0.8% | 0.62% | +38.6% |
| NYXOAH SA | $1,410,536 | -12.0% | 200,076 | 0.0% | 0.44% | +7.1% | ||
| APREA THERAPEUTICS INC | $1,166,620 | +32.3% | 280,000 | 0.0% | 0.36% | +61.2% | ||
| PRLD | New | PRELUDE THERAPEUTICS INC | $1,081,500 | – | 350,000 | +100.0% | 0.34% | – |
| CORBUS PHARMACEUTICALS HLDGS INC | $1,011,000 | -14.0% | 150,000 | 0.0% | 0.31% | +4.7% | ||
| RPTX | REPARE THERAPEUTICS INC | $918,672 | +14.2% | 76,049 | 0.0% | 0.28% | +38.5% | |
| New | SIGHT SCIENCES INC | $831,376 | – | 246,699 | +100.0% | 0.26% | – | |
| MODULAR MED INC | $799,648 | +18.4% | 689,352 | 0.0% | 0.25% | +44.2% | ||
| New | HARPOON THERAPEUTICS INC | $677,109 | – | 168,017 | +100.0% | 0.21% | – | |
| FUSN | FUSION PHARMACEUTICALS INC | $639,694 | -44.3% | 246,036 | 0.0% | 0.20% | -32.2% | |
| ASLAN PHARMACEUTICALS LTDspon ads new | $477,802 | -48.5% | 254,150 | 0.0% | 0.15% | -37.3% | ||
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $421,701 | -37.6% | 97,616 | -4.8% | 0.13% | -23.8% |
| INGN | Sell | INOGEN INC | $275,585 | -78.6% | 52,794 | -52.7% | 0.08% | -74.1% |
| NXTC | NEXTCURE INC | $167,700 | -28.3% | 130,000 | 0.0% | 0.05% | -13.3% | |
| MBRX | Sell | MOLECULIN BIOTECH INC | $115,951 | -34.0% | 271,230 | -10.6% | 0.04% | -20.0% |
| VINC | VINCERX PHARMA INC | $103,069 | -22.3% | 102,049 | 0.0% | 0.03% | -5.9% | |
| ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $69,800 | -10.5% | 400,000 | 0.0% | 0.02% | +10.0% | ||
| CMAX | CAREMAX INC | $65,171 | -31.8% | 30,741 | 0.0% | 0.02% | -16.7% | |
| HUMACYTE INC*w exp 08/27/202 | $33,439 | -6.5% | 49,998 | 0.0% | 0.01% | +11.1% | ||
| CMAXW | CAREMAX INC*w exp 06/08/202 | $2,369 | -49.8% | 12,808 | 0.0% | 0.00% | 0.0% | |
| FGEN | Exit | FIBROGEN INC | $0 | – | -11,600 | -100.0% | -0.01% | – |
| FGEN | Exit | FIBROGEN INCput | $0 | – | -11,600 | -100.0% | -0.01% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -6,431,349 | -100.0% | -0.58% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -6,995,381 | -100.0% | -1.02% | – |
| HUM | Exit | HUMANA INC | $0 | – | -13,000 | -100.0% | -1.48% | – |
| PDCO | Exit | PATTERSON COS INC | $0 | – | -245,000 | -100.0% | -2.07% | – |
| AXNX | Exit | AXONICS INC | $0 | – | -164,017 | -100.0% | -2.10% | – |
| ISRG | Exit | INTUITIVE SURGICAL INCput | $0 | – | -35,500 | -100.0% | -3.09% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INCput | $0 | – | -34,500 | -100.0% | -3.10% | – |
| MED | Exit | MEDIFAST INCput | $0 | – | -190,000 | -100.0% | -4.45% | – |
| SYK | Exit | STRYKER CORPORATIONput | $0 | – | -80,000 | -100.0% | -6.21% | – |
| SWAV | Exit | SHOCKWAVE MED INCput | $0 | – | -154,400 | -100.0% | -11.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.